difference bet. diclofenac na and diclofenac k
Reading File
Searching the Web
diclofenac sodium vs diclofenac potassium pharmacokinetics clinical differences
Finding Sources
Reading File
Here is a clear, side-by-side breakdown of the two salts:
Diclofenac Sodium vs. Diclofenac Potassium
Both are salts of the same active molecule - diclofenac - a phenylacetic acid derivative and relatively non-selective COX inhibitor. The difference lies in the counterion, which affects solubility, formulation, onset of action, and clinical use.
Key Differences at a Glance
| Property | Diclofenac Sodium (Na) | Diclofenac Potassium (K) |
|---|---|---|
| Salt / Ion | Sodium salt | Potassium salt |
| Water solubility | Lower | Higher |
| Tablet coating | Usually enteric-coated | Usually immediate-release (uncoated) |
| Onset of action | 30-60 min (oral); peak plasma ~2-4 hours | 15-30 min; peak plasma ~30-54 min |
| Duration | Longer, sustained | Shorter per dose |
| Typical dose | 50 mg TDS or 75 mg BD (oral); SR 100 mg OD | 25-50 mg TDS |
| Best suited for | Chronic inflammatory conditions (OA, RA, AS) | Acute pain - dental, dysmenorrhoea, migraine, gout, post-op |
| Topical/ophthalmic | 0.1% ophthalmic solution (Voltaren), 1% and 3% gels | Primarily oral |
| GI side effects | Enteric coating reduces immediate GI irritation | Faster absorption; GI risk if not taken with food |
| Common brands | Voveran, Voltaren (SR/tablets) | Cataflam, Cambia |
| OTC availability | Prescription in most countries | Was OTC in some markets; withdrawn due to CV concerns |
Why the Difference Matters Clinically
-
Speed vs. Sustained effect: The potassium salt is more water-soluble, so it dissolves and absorbs faster. The Pharmaceutical Journal notes peak plasma levels are reached in 30-54 minutes with diclofenac K vs. 2-4 hours with enteric-coated diclofenac Na.
-
Same total exposure: The area under the curve (AUC) is essentially the same - you get the same total drug, just at different speeds. The mechanism of action (COX inhibition, prostaglandin suppression) is identical once absorbed.
-
Enteric coating on Na: Diclofenac sodium tablets are often enteric-coated specifically to slow dissolution, protect the stomach, and allow timed release - further delaying onset but improving GI tolerability for long-term use.
-
Post-op / acute pain: NIHR evidence indicates a single dose of diclofenac potassium 50 mg is more effective for postoperative pain compared to enteric-coated diclofenac sodium, because of earlier and higher initial plasma concentration.
-
Synovial fluid kinetics: Peak diclofenac levels in synovial fluid lag ~2-4 hours behind plasma peaks. For chronic arthritis, diclofenac Na's slower plasma rise still achieves effective synovial levels - making the speed difference largely irrelevant for regular dosing.
-
Hepatotoxicity: Both forms share the same risk - diclofenac causes aminotransferase elevation more commonly than other NSAIDs (Katzung's Basic and Clinical Pharmacology, 16th Ed).
-
Potassium load: The potassium content in a 50 mg diclofenac K tablet is very small (~4.7 mg of K+) - not clinically significant in most patients. However, patients with renal impairment or those on ACE inhibitors / K-sparing diuretics should avoid all oral NSAIDs regardless.
Summary
- Choose diclofenac K when rapid analgesia is needed (dysmenorrhoea, migraine, acute dental/gout pain, post-op).
- Choose diclofenac Na for chronic inflammatory conditions requiring sustained, round-the-clock anti-inflammatory coverage.
- Both carry the same class warnings: GI ulceration, cardiovascular risk, nephrotoxicity, and hepatotoxicity.
dose
Here are the standard doses for both salts:
Diclofenac Dosing
Diclofenac Sodium (Na)
| Formulation | Dose | Frequency | Max Daily Dose |
|---|---|---|---|
| Immediate-release tablet | 50 mg | TDS (3x/day) | 150 mg/day |
| Sustained-release (SR/XR) | 75 mg | BD (2x/day) | 150 mg/day |
| Sustained-release (SR) | 100 mg | OD (1x/day) | 150 mg/day |
| Suppository (rectal) | 50-100 mg | OD-BD | 150 mg/day |
| Topical gel (1%) | 2-4 g applied | Q6-8h | - |
| Ophthalmic (0.1%) | 1 drop | QID | - |
| IM injection | 75 mg | OD (max 2 days) | 150 mg/day |
Diclofenac Potassium (K)
| Formulation | Dose | Frequency | Max Daily Dose |
|---|---|---|---|
| Immediate-release tablet | 25-50 mg | TDS (3x/day) | 150 mg/day |
| Acute pain (single dose) | 50 mg | PRN | 150 mg/day |
| Powder for oral solution (Cambia) | 50 mg | Single dose for migraine | 50 mg |
Pediatric Dosing (Diclofenac)
- 1-14 years: 1-3 mg/kg/day in divided doses
- JRA: up to 3 mg/kg/day
Special Populations
| Condition | Recommendation |
|---|---|
| Renal impairment | Avoid if GFR < 30 mL/min |
| Hepatic impairment | Use with caution; monitor LFTs |
| Elderly | Start at lowest effective dose; use shortest duration |
| Pregnancy | Avoid after 20 weeks; contraindicated in 3rd trimester |
Key point: The maximum dose is the same (150 mg/day) for both salts - the difference is only in how quickly each dose acts, not in total daily dosage. Always take with food or milk to reduce GI irritation.
This is a shared conversation. Sign in to Orris to start your own chat.